Michael P. Johnson

Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

Michael P. Johnson, Andrew J. Hoffman, David E. Nichols · European Journal of Pharmacology · 1986 · 307 citations

Psychoactive Drug, Psychiatry, Neurophysiology +9

Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in Rats

Carrie G. Markgraf, Nelson L. Velayo, Michael P. Johnson et al. · Stroke · 1998 · 245 citations · Full text

Identification of a GABAB Receptor Subunit, gb2, Required for Functional GABAB Receptor Activity

Gordon Ng, Janet Clark, Nathalie Coulombe et al. · Journal of Biological Chemistry · 1999 · 212 citations · Full text

Molecular Biology, Social Sciences, Monomeric Receptors +17

Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor:  Synthesis and Subtype Selectivity of <i>N</i>-(4-(2-Methoxyphenoxy)phenyl)-<i>N</i>-(2,2,2− trifluoroethylsulfonyl)pyrid-3-ylmethylamine

Michael P. Johnson, Melvyn Baez, G. Erik Jagdmann et al. · Journal of Medicinal Chemistry · 2003 · 181 citations · Full text

Allosteric Potentiators, Molecular Pharmacology, Biochemistry +15

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

Michael P. Johnson, David A. Barda, Thomas C. Britton et al. · Psychopharmacology · 2005 · 154 citations

Psychoactive Drug, Psychiatry, Behavioral Neuroscience +13